Skip to main content
Akash Patnaik, MD, Oncology, Chicago, IL

Akash Patnaik MD


Associate Professor of Medicine Deputy Section Chief for Translational Research Section of Hematology/Oncology Program Leader, Clinical & Experimental Therapeutics Program

Join to View Full Profile
  • 5841 S Maryland AveChicago, IL 60637

  • Phone+1 888-824-0200

  • Fax+1 773-702-9268

Dr. Patnaik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 2003
  • Harvard Medical School
    Harvard Medical SchoolPost-Doctoral Fellowship
  • Harvard Medical School
    Harvard Medical SchoolPost-Doctoral Fellowship

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2015 - 2026
  • MA State Medical License
    MA State Medical License 2006 - 2017
  • MN State Medical License
    MN State Medical License 2004 - 2007
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Free Online Yoga & Meditation Program Supports Healthcare Workers' Mental Health
    Free Online Yoga & Meditation Program Supports Healthcare Workers' Mental HealthMarch 23rd, 2021
  • Author Correction: Pan-Cancer Image-Based Detection of Clinically Actionable Genetic Alterations
    Author Correction: Pan-Cancer Image-Based Detection of Clinically Actionable Genetic AlterationsNovember 3rd, 2020
  • PARP Inhibitor Becomes New Treatment Option for Some Men with Advanced Prostate Cancer
    PARP Inhibitor Becomes New Treatment Option for Some Men with Advanced Prostate CancerAugust 14th, 2020
  • Join now to see all

Grant Support

  • Targeting the cGAS/STING Pathway to Overcome Resistance to Immune Checkpoint Inhibitors in PTEN-deficient Prostate CancerUNIVERSITY OF CHICAGO2022–2027

Professional Memberships

Other Languages

  • Hindi

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: